A new way forward in cancer care

The answer to your cancer is in your data.
We find it.

CureSeek is an AI-powered second opinion platform that synthesizes your scans, pathology, genomics, and history with the latest oncology research — surfacing personalized, evidence-backed treatment options for you and your care team.

Request your analysis See how it works

HIPAA-compliant infrastructure

Clinician validated

Built by oncology specialists

scroll

/ A PATIENT'S STORY

Hope, when there were no answers left.

Pathway analysis

Six years later

Cancer-free

And thriving

At 16, she was placed on hospice with advanced brain cancer — given one month to live after exhausting every standard treatment. Instead of accepting that outcome, Dr. Kesari analyzed her full molecular data, mapped the biology driving her disease, and identified a targeted, repurposed therapy.

Six years later, she is alive and thriving. Over the past 25 years, this same pathway-based approach has been applied to hundreds of advanced cancer patients — often when conventional medicine had no remaining options.

The patient's story is the foundation of CureSeek. Our platform was built to scale this proven methodology so that more patients can receive the same level of analysis — faster, and wherever they are.

/ THE PROBLEM

The science exists. The challenge is synthesis.

Even when actionable biomarkers are present in a patient's data, too many people still don't receive the best-matched therapies. CureSeek exists to close that gap.

Cancer is thousands of diseases.

Tumors with the same name can be molecularly distinct — and respond to entirely different treatments. Yet decisions are often still made based on tissue of origin alone.

The data is fragmented.

Genomic panels, pathology, imaging, and clinical history live in separate systems and formats. Synthesizing them into a coherent strategy is slow, manual work.

Time is the hardest variable.

Expert analysis can take weeks. For patients with advanced or aggressive disease, that delay can mean missing the therapies that matter most.

How it works

01 / 04

01 / Intake

Your story, securely uploaded.

Scans, pathology, genomics, surgical notes, EHR exports. Encrypted in transit and at rest, structured by our medical team within hours — not weeks.

Researcher reviewing translucent medical data on a glass display in a modern laboratory.

Glowing translucent DNA double helix representing genomic analysis.

Stacked translucent medical scan slices with glowing tumor heatmap regions.

Abstract molecular bonds and atomic structures arranged in a precise grid.

How it works

From scattered records to a clear, personal picture.

We bring your records, scans, and lab results together in one place — then apply the kind of careful, multidisciplinary review usually reserved for top cancer centers, with the speed and consistency of modern technology.

Your data

Genetic testing→
Pathology→
Scans & imaging→
Medical history→

Our analysis

Bringing it all together→
Mapping the biology→
Matching to therapies→
Finding trials for you→

Your report

Clear summary→
Treatment options→
Other promising drugs→
Trials you may qualify for→

All your data, in one place

Genetic testing, pathology, scans, and your medical history come together so nothing important gets lost between providers.

Built around your biology

Our analysis is trained on decades of real patient outcomes, so the recommendations reflect the specific drivers of your cancer.

Backed by published research

Every treatment option, repurposed medication, and trial match is linked to the peer-reviewed evidence behind it.

Private and secure

Your information is encrypted and protected with HIPAA-aligned safeguards. You decide what gets shared, and with whom.

/ DELIVERABLE

The CureSeek Insights Report.

A practical, evidence-backed roadmap designed to be useful in the real world — for patients, families, and the oncologists guiding their care.

INSIGHTS_REPORT.PDF

CLINICIAN VALIDATED

CASE · 0042

Personalized treatment roadmap

0VARIANTS

0MATCHES

0TRIALS

A pathway-level summary of the biology driving your specific cancer
Targeted therapy options matched to your molecular profile
Repurposed and off-label drug candidates with supporting evidence
Relevant clinical trials filtered to your situation
References to the published research behind every recommendation
A plain-language overview written for you and your family

CureSeek does not replace your oncologist. The Insights Report is designed to inform shared decision-making between you and your care team.

/ WHY CURESEEK

Proven medicine, made practical at scale.

We're not introducing a new theory of cancer care. We're taking a methodology that has worked for individual patients for decades — and making it accessible to many more.

0+ yrsPathway-based oncology

0+Consented cases analyzed

0Modalities fused per case

0hFrom intake to first signals

Built on decades of real outcomes

CureSeek is grounded in 25+ years of pathway-based oncology practice — not a theoretical model. Our methodology has been refined across hundreds of advanced patient cases.

Multi-modal by design

We integrate genomics, pathology, imaging, and clinical context together — because the answer rarely lives in any single dataset alone.

A learning system

Every consented case strengthens the platform. Insights become more accurate over time, and the cost of arriving at them goes down.

Patient-first, clinician-validated

Reports are written to be useful to both patients and oncologists, and every recommendation is reviewed by trained clinicians before delivery.

/ TEAM

Decades of medicine. The technology to scale it.

CureSeek is built by a team operating in stealth — physician-scientists, geneticists, computational biologists, AI engineers, and repeat founders who have spent their careers at the intersection of precision medicine and technology. Collectively, they bring deep clinical, research, and engineering expertise to the mission of finding the right treatment for every patient.

Precision Oncology & Neurology

Harvard-trained physician-scientists with over 25 years applying pathway-based precision medicine to advanced cancer patients, with prior leadership across leading academic and clinical research institutions.

Human Genetics & Translational Biology

PhD in Human Genetics (UCLA) with 15+ years in biotech R&D at organizations including Capsida and Amgen, translating genomic discovery into therapeutic programs.

Computational & Cancer Biology

Training spanning UCLA David Geffen School of Medicine, a Stanford post-doctoral fellowship in cancer biology, a PhD from OHSU School of Medicine, and director-level experience leading computational biology.

Applied AI & Engineering

Builders of production LLM, RAG pipeline, and AI agent systems, backed by engineering and technology leadership across enterprise platforms and multiple startups delivering secure, scalable healthcare systems.

Founders & Operators

Serial entrepreneurs whose prior ventures include Cancer Commons, PatientsLikeMe, and CollabRx — with a track record of building patient-centered, data-driven companies from the ground up.

AI & Cloud Platform Engineering

Deep expertise across AI, computer vision, natural language processing, and LLM training, paired with a history of building SaaS products and mission-critical cloud systems at scale.

/ FAQ

Questions, answered honestly.

Have a question that isn't here? Reach out to our team — we're happy to talk through your situation.

/ GET IN TOUCH

Take the next step toward a clearer path.

Tell us a little about your situation. A member of our team will follow up to walk you through the process and answer any questions.

DIRECT

contact@cureseek.com

For urgent medical concerns, please contact your care team or call your local emergency services.

The answer to your cancer is in your data.
We find it.

Hope, when there were no answers left.